MCK - Mckesson Corporation Stock Analysis
Mckesson Corporation (MCK) is a publicly traded company listed on the NYSE. It operates in the Medical Distribution industry, part of the broader Healthcare sector. The company has a market capitalization of 103.74B, generates annual revenue of 387.09B, and reports net income of 4.03B. As of the latest data, the stock is trading at 840.46 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company has very low leverage, which may indicate conservative financial management or underutilization of debt. The dividend yield (0.35%) is modest, often associated with growth-oriented companies. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Buy (4.18), indicating current market sentiment. Institutional ownership is reported at 90.51%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 44.05%, trading within a 52-week range of 570.51 - 895.58.
MCK - Mckesson Corporation
840.46
Analyst Consensus
Buy 4.18
MCK – Analyst Rating Summary
- Strong Buy: 7
- Buy: 12
- Hold: 3
- Sell: 0
- Strong Sell: 0
- Total Analysts: 22
| Index: | S&P 500 | P/E: | 26.17 | EPS (ttm): | 32.12 | Insider Own: | 0.03% | Shs Outstand: | 124.00M | Perf Week: | 2.99% |
| Market Cap: | 103.74B | Forward P/E: | 19.16 | EPS next Y: | 43.86 | Insider Trans: | -40.11% | Shs Float: | 123.39M | Perf Month: | 3.77% |
| Income(ttm): | 4.03B | PEG: | 1.31 | EPS next Q: | 9.16 | Inst Own: | 90.51% | Short Float: | 1.61% | Perf Quarter: | 8.38% |
| Revenue(ttm): | 387.09B | P/S: | 0.27 | EPS this Y: | 17.82% | Inst Trans: | -0.98% | Short Ratio: | 2.87 | Perf Half Y: | 18.41% |
| Book/sh: | -14.02 | P/B: | - | EPS next Y: | 12.63% | ROA: | 5.15% | Short Interest: | 1.99M | Perf Year: | 44.05% |
| Cash/sh: | 33.29 | P/C: | 25.25 | EPS next 5Y: | 14.67% | ROE: | - | 52W Range: | 570.51 - 895.58 | Perf YTD: | 2.46% |
| Dividend Est.: | 2.91 (0.35%) | P/FCF: | 16.32 | EPS past 3/5Y: | 52.67% 39.07% | ROIC: | 66.90% | 52W High: | 895.58 -6.15% | Beta: | 0.41 |
| Dividend TTM: | 3.06 (0.36%) | Quick Ratio: | 0.50 | Sales past 3/5Y: | 10.80% 9.22% | Gross Margin: | 3.24% | 52W Low: | 570.51 47.32% | Perf 5Y: | 358.27% |
| Dividend Ex-Date: | Dec 01, 2025 | Current Ratio: | 0.88 | EPS Y/Y TTM: | 66.17% | Oper. Margin: | 1.24% | RSI (14): | 58.93 | Volatility: | 1.88% 1.74% |
| Employees: | 45000 | Debt/Eq: | - | Sales Y/Y TTM: | 17.23% | Profit Margin: | 1.04% | Recom: | 1.65 | Target Price: | 951.33 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | - | EPS Q/Q: | 378.72% | Payout: | 10.69% | Rel Volume: | 0.84 | Prev Close: | 844.13 |
| Sales Surprise: | -0.95% | EPS Surprise: | 9.20% | Sales Q/Q: | 10.14% | Earnings: | Feb 04 AMC | Avg Volume: | 693.01K | Price: | 840.46 |
| SMA20: | 1.84% | SMA50: | 0.77% | SMA200: | 12.45% | Undervalued: 13.19% | Volume: | 585,450 | Change: | -0.43% | |
Graham Classic formula value: 1091.4
(P/E=8 * 1g) Min value: 653.86
(current P/E * 2g) Max value: 1601.04
Average value: 1115.43
About Mckesson Corporation
McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.